Company profile: NuGEN
1.1 - Company Overview
Company description
- Provider of innovative genomics sample preparation solutions enabling scientists to access true biology in all samples, independent of type, quality and amount, for analysis on leading analytical platforms, ensuring robust and reproducible results for researchers seeking to predict disease
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NuGEN
Constellation Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel therapeutics in the emerging field of epigenetics, focusing on selective regulators of epigenetic function critical to controlling gene expression; the first biopharmaceutical company dedicated to this area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Constellation Pharmaceuticals company profile →
Actogenix
HQ: Belgium
Website
- Description: Provider of biopharmaceutical development and commercialization of a new generation of biological drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Actogenix company profile →
InVivo Biotech Services
HQ: Germany
Website
- Description: Provider of contract manufacturing services for development and production of monoclonal antibodies and recombinant proteins. Offerings include antibody production from hybridomas (small to large scale), recombinant protein expression in bacterial and mammalian systems, non-GMP cell line development, research antibodies produced in HEK under serum-free conditions, and SARS‑CoV‑2 antigens and antibodies for immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InVivo Biotech Services company profile →
Verve Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage genetic medicines for cardiovascular disease, including gene editing therapies VERVE-101 targeting PCSK9 to lower LDL-C in heterozygous familial hypercholesterolemia and ASCVD, and VERVE-201 targeting ANGPTL3 for homozygous and refractory hypercholesterolemia, enabled by a proprietary GalNAc-LNP liver delivery system, with medicines evaluated in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verve Therapeutics company profile →
Genomic Vision
HQ: France
Website
- Description: Provider of novel genetic tests and research tools for life sciences, developed and commercialized using Molecular Combing, a proprietary single DNA molecule detection technology, combined with biomarker discovery; focused on DNA analysis and genetic testing in cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomic Vision company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NuGEN
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NuGEN
2.2 - Growth funds investing in similar companies to NuGEN
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NuGEN
4.2 - Public trading comparable groups for NuGEN
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →